Charles Schwab reports 3.64M shares (4.75%) of Accendra Health
Charles Schwab Investment Management Inc. filed Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 3,635,526 shares of Accendra Health Inc. common stock (CUSIP 690732102), representing 4.75% of the class as of 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Charles Schwab Investment Management Inc. filed Amendment No. 1 to a Schedule 13G/A reporting beneficial ownership of 3,635,526 shares of Accendra Health Inc. common stock (CUSIP 690732102), representing 4.75% of the class as of 03/31/2026. The filing shows sole voting and sole dispositive power over the same 3,635,526 shares. The amendment is signed by Omar Aguilar on 05/13/2026.
Insights
Large passive holding disclosed: 3,635,526 shares, 4.75% ownership.
The filing lists 3,635,526 shares and a 4.75% stake as of 03/31/2026. It is an amended Schedule 13G/A, which institutions commonly use to report passive or qualifying ownership.
Documented powers show sole voting and sole dispositive authority over 3,635,526 shares. Future disclosures may show changes if the holder crosses the 5% threshold or alters voting status.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficially owned financial
Sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Charles Schwab hold in Accendra Health (ACH)?
Is this filing an initial report or an amendment for ACH?
Does this Schedule 13G/A indicate Charles Schwab is a 5% owner of ACH?
AI-generated analysis. How Rhea-AI works. Not financial advice.